Frank E Jaumot bought $14k of NUTX
director at Nutex Health Inc.. 150 shares at an average of $93.56, traded Mar 20, 2026, filed Mar 23, 2026.
Score components
- +15RoleDirector
- 0Trade size$14k at market
- +8Relative to holdingsFirst purchase: no shares before this trade
- +8Price context53% below the 52-week high
- +15Cluster4 insiders buying within 14 days
- 0Repeat buyingFirst buy in 90 days
- 0Track recordToo few past buys to judge (0 with prices)
What happened after comparable buys
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +14.1%, 3m +58.1%, 6m +112.1%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001303609-26-000002, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | POpen-market purchase Common Stock | +150 | $93.56 | $14k | 150 | Mar 23, 2026 |
Related signals
Other insiders at Nutex Health Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 31Weak | NUTXsell Nutex Health Inc. | Scott J Saunders director | $43k 203 shares | -34% | |
| 43Moderate | Nutex Health Inc. | Warren Hosseinion President | $24k 252 shares | +3% | |
| 33Weak | Nutex Health Inc. | Kelvin Spears director | $945 10 shares | +0% | |
| 38Weak | Nutex Health Inc. | Pamela W. Montgomery Chief Legal Officer-Healthcare | $7,021 79 shares | +3% | |
| 43Moderate | NUTXbuy Nutex Health Inc. | Jon Christian Bates Chief Financial Officer | $103k 750 shares | +15% | |
| 37Weak | NUTXbuy Nutex Health Inc. | Jon Christian Bates Chief Financial Officer | $82k 1,000 shares | +26% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.